Horizon CEO Joel White shared his insights on the impact 2022 had on health policy during “The Year Ahead in Health Policy” webinar sponsored by The Commonwealth Fund.
The Benefits Pro article, “After productive year in 2022, health care policymakers expected to focus on implementation” quoted White as saying, “This was a busy past Congress, and a lot ended up happening, I would say the most significant thing was the Inflation Reduction Act. That was the biggest change in drug pricing and the approach to drug pricing in 40 years. With the negotiated drug price controls in that law, it will fundamentally redesign how drug pricing works and how markets operate around prescription drugs.”